Imipramine disposition in users of oral contraceptive steroids
The DOI matches its Crossref record.
Abstract
Ten women on long-term, low-dose estrogen oral contraceptive steroids (OCS) and eight age-matched drug-free female controls received an intravenous infusion of 12.5 mg imipramine. Eleven (six OCS users and five controls) also took a 50-mg oral dose of imipramine on another occasion. After intravenous injection, volume of distribution was much the same in the OCS and control groups and clearance was of the same order (899 and 975 ml/min). Elimination t1/2 was prolonged in OCS users after intravenous doses (17.8 vs 25.5 hr) but did not change after oral doses (18.4 vs 19.1 hr). Imipramine plasma protein binding was of the same order in both groups. Absolute bioavailability increased in OCS users (from 27.1% vs 44.1%), which resulted in a trend toward decreased apparent oral clearance (from 4649 vs 2322 ml/min). Women who used OCS regularly show little change in imipramine kinetics after intravenous dosing. After oral dosing absolute systemic bioavailability increased, resulting in decreased apparent oral clearance in the absence of any change in oral elimination t1/2. Imipramine (with high first-pass hepatic extraction) is nonrestrictively cleared, with drug elimination predominantly a function of hepatic blood flow. These data are consistent with OCS inhibition of hepatic imipramine oxidation with no alteration in hepatic blood flow resulting from chronic OCS use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Strategies and Methods for Research on Sex Differences in Brain and Behavior
Becker, J. B., Arnold, A. P., Berkley, K. J., Blaustein, J. D., Eckel, L. A., Hampson, E., Herman, J. P., Marts, S., Sadee, W., Steiner, M., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1142 · Cited by 801
Metabolism of Tricyclic Antidepressants
Rudorfer, M. V., & Potter, W. Z. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006949816036 · Cited by 296
Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.5.587 · Cited by 269
Impairment of Caffeine Clearance by Chronic Use of Low-Dose Oestrogen-Containing Oral Contraceptives
Abernethy, D. R., & Todd, E. L. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544361 · Cited by 195
Self-citationDrug interactions between hormonal contraceptives and psychotropic drugs: a systematic review
Berry-Bibee, E. N., Kim, M.-J., Simmons, K. B., Tepper, N. K., Riley, H. E. M., Pagano, H. P., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.07.011 · Cited by 52
Metadata
- Authors
- Abernethy, D. R., Greenblatt, D. J., & Shader, R. I.
- Venue
- Clinical Pharmacology and Therapeutics
- Publisher
- Wiley
- Published
- 1984-06
- Volume
- 35
- Issue
- 6
- Pages
- 792-797
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2022167440
- Cited by
- 67
- References
- 0
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imipramine disposition in users of oral contraceptive steroids. https://app.cochat.ai/papers/10.1038/clpt.1984.114
- The paper
- Abernethy, D. R., Greenblatt, D. J., & Shader, R. I. (1984). Imipramine disposition in users of oral contraceptive steroids. Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.1984.114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.